| NCT ID | NCT04571658 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Nephrotic Syndrome in Children |
| Study Type | INTERVENTIONAL |
| Enrollment | 375 participants |
| Start Date | 2022-05-02 |
| Primary Completion | 2029-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 375 participants in total. It began in 2022-05-02 with a primary completion date of 2029-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physician investigators.
Eligibility Criteria
Inclusion Criteria: 1. Consented and eligible participants in the biopsied or non-biopsied cohorts of the NEPTUNE observational study 2. Must be potentially eligible for the NEPTUNE Match partnering trials (e.g. if no trial is enrolling a participant under age 6, those under 6 are not eligible). Note: NEPTUNE Match partnering trials and associated eligibility criteria are expected to be dynamic and change as trial protocols are developed, activated, and amended. 3. Regular nephrology healthcare provided at a NEPTUNE study site. 4. Willing and able to consent, and as appropriate assent, to participate in NEPTUNE Match Exclusion Criteria: Currently non-NEPTUNE observational study participants are not eligible to be matched to a clinical trial using these biomarker assessments. Exclusion Criteria: 1\. Non-English or non-Spanish speaking
Contact & Investigator
Matthias Kretzler, MD
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT04571658 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 80 Years, studying Nephrotic Syndrome in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04571658 currently recruiting?
Yes, NCT04571658 is actively recruiting participants. Contact the research team at heturner@med.umich.edu for enrollment information.
Where is the NCT04571658 trial being conducted?
This trial is being conducted at Atlanta, United States, Chicago, United States, Kansas City, United States, Baltimore, United States and 11 additional locations.
Who is sponsoring the NCT04571658 clinical trial?
NCT04571658 is sponsored by University of Michigan. The principal investigator is Matthias Kretzler, MD at University of Michigan. The trial plans to enroll 375 participants.